哮喘与 COVID-19：我们现在知道什么。

IF 1 Q4 RESPIRATORY SYSTEM

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine Pub Date : 2020-10-23 eCollection Date: 2020-01-01 DOI:10.1177/1179548420966242

Alexzandra Hughes-Visentin, Anthea B Mahesan Paul

{"title":"哮喘与 COVID-19：我们现在知道什么。","authors":"Alexzandra Hughes-Visentin, Anthea B Mahesan Paul","doi":"10.1177/1179548420966242","DOIUrl":null,"url":null,"abstract":"The COVID-19 pandemic has presented challenges in symptomology identification, diagnosis, management and follow-up in common respiratory diseases, and in particular asthma. Research is rapidly ongoing to try and understand how the SARS-CoV-2 virus affects individuals with asthma, as well as, how underlying asthma affects Covid-19 risk, symptomology and prognosis. In light of this unique medical challenge, clinicians are faced with case-by-case based decisions to implement or continue current asthma therapy. This review will discuss the current literature regarding asthma and COVID-19 based on best available evidence at this time (See box 1).","PeriodicalId":44269,"journal":{"name":"Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine","volume":"14 ","pages":"1179548420966242"},"PeriodicalIF":1.0000,"publicationDate":"2020-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a5/fa/10.1177_1179548420966242.PMC7588760.pdf","citationCount":"0","resultStr":"{\"title\":\"Asthma and COVID-19: What do we know now.\",\"authors\":\"Alexzandra Hughes-Visentin, Anthea B Mahesan Paul\",\"doi\":\"10.1177/1179548420966242\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The COVID-19 pandemic has presented challenges in symptomology identification, diagnosis, management and follow-up in common respiratory diseases, and in particular asthma. Research is rapidly ongoing to try and understand how the SARS-CoV-2 virus affects individuals with asthma, as well as, how underlying asthma affects Covid-19 risk, symptomology and prognosis. In light of this unique medical challenge, clinicians are faced with case-by-case based decisions to implement or continue current asthma therapy. This review will discuss the current literature regarding asthma and COVID-19 based on best available evidence at this time (See box 1).\",\"PeriodicalId\":44269,\"journal\":{\"name\":\"Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine\",\"volume\":\"14 \",\"pages\":\"1179548420966242\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2020-10-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a5/fa/10.1177_1179548420966242.PMC7588760.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/1179548420966242\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1179548420966242","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}

引用次数: 0

摘要

COVID-19 大流行给常见呼吸道疾病，特别是哮喘的症状识别、诊断、管理和随访带来了挑战。目前正在迅速开展研究，试图了解 SARS-CoV-2 病毒如何影响哮喘患者，以及潜在的哮喘如何影响 COVID-19 的风险、症状和预后。鉴于这一独特的医学挑战，临床医生面临着根据具体情况决定是实施还是继续目前的哮喘治疗。本综述将根据目前可获得的最佳证据讨论有关哮喘和 COVID-19 的现有文献（见方框 1）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Asthma and COVID-19: What do we know now.

The COVID-19 pandemic has presented challenges in symptomology identification, diagnosis, management and follow-up in common respiratory diseases, and in particular asthma. Research is rapidly ongoing to try and understand how the SARS-CoV-2 virus affects individuals with asthma, as well as, how underlying asthma affects Covid-19 risk, symptomology and prognosis. In light of this unique medical challenge, clinicians are faced with case-by-case based decisions to implement or continue current asthma therapy. This review will discuss the current literature regarding asthma and COVID-19 based on best available evidence at this time (See box 1).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine RESPIRATORY SYSTEM-

CiteScore

4.20

自引率

0.00%

发文量

审稿时长

8 weeks